Literature DB >> 29758946

Gut Microbiota is Altered in Patients with Alzheimer's Disease.

Zhen-Qian Zhuang1, Lin-Lin Shen1, Wei-Wei Li1, Xue Fu2, Fan Zeng1, Li Gui3, Yang Lü2, Min Cai4, Chi Zhu1, Yin-Ling Tan5, Peng Zheng6, Hui-Yun Li1, Jie Zhu1, Hua-Dong Zhou1, Xian-Le Bu1, Yan-Jiang Wang1.   

Abstract

Previous studies suggest that gut microbiota is associated with neuropsychiatric disorders, such as Parkinson's disease, amyotrophic lateral sclerosis, and depression. However, whether the composition and diversity of gut microbiota is altered in patients with Alzheimer's disease (AD) remains largely unknown. In the present study, we collected fecal samples from 43 AD patients and 43 age- and gender-matched cognitively normal controls. 16S ribosomal RNA sequencing technique was used to analyze the microbiota composition in feces. The composition of gut microbiota was different between the two groups. Several bacteria taxa in AD patients were different from those in controls at taxonomic levels, such as Bacteroides, Actinobacteria, Ruminococcus, Lachnospiraceae, and Selenomonadales. Our findings suggest that gut microbiota is altered in AD patients and may be involved in the pathogenesis of AD.

Entities:  

Keywords:  16S ribosomal RNA sequencing; Alzheimer’s disease; amyloid-β peptide; gut microbiota

Mesh:

Substances:

Year:  2018        PMID: 29758946     DOI: 10.3233/JAD-180176

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  142 in total

Review 1.  Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.

Authors:  Aleah Holmes; Carson Finger; Diego Morales-Scheihing; Juneyoung Lee; Louise D McCullough
Journal:  Transl Res       Date:  2020-08-02       Impact factor: 7.012

Review 2.  The role of the gut microbiome in mediating neurotoxic outcomes to PCB exposure.

Authors:  Kavi M Rude; Ciara E Keogh; Mélanie G Gareau
Journal:  Neurotoxicology       Date:  2019-08-24       Impact factor: 4.294

Review 3.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

Review 4.  The Microbiome as a Modifier of Neurodegenerative Disease Risk.

Authors:  P Fang; S A Kazmi; K G Jameson; E Y Hsiao
Journal:  Cell Host Microbe       Date:  2020-08-12       Impact factor: 21.023

5.  Gut microbes in neurocognitive and mental health disorders.

Authors:  Tyler Halverson; Kannayiram Alagiakrishnan
Journal:  Ann Med       Date:  2020-08-31       Impact factor: 4.709

Review 6.  Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.

Authors:  Priyanka Nagu; Arun Parashar; Tapan Behl; Vineet Mehta
Journal:  J Mol Neurosci       Date:  2021-04-08       Impact factor: 3.444

Review 7.  Cognitive complications of cancer and cancer-related treatments - Novel paradigms.

Authors:  Naomi Lomeli; Javier Lepe; Kalpna Gupta; Daniela A Bota
Journal:  Neurosci Lett       Date:  2021-02-11       Impact factor: 3.046

8.  Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease.

Authors:  John P Haran; Beth A McCormick
Journal:  Gastroenterology       Date:  2020-12-08       Impact factor: 22.682

9.  Gut microbial involvement in Alzheimer's disease pathogenesis.

Authors:  Yu Zhang; Rulin Geng; Qiuyun Tu
Journal:  Aging (Albany NY)       Date:  2021-05-10       Impact factor: 5.682

Review 10.  Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives.

Authors:  Bin-Lu Sun; Yang Chen; Dong-Yu Fan; Chi Zhu; Fan Zeng; Yan-Jiang Wang
Journal:  Sci China Life Sci       Date:  2020-10-23       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.